BICO Group AB (publ) (CLLKF) Stock Price, News & Analysis

Company Overview

BICO Group AB (publ), formerly known as CELLINK, is a Sweden-based life science technology company focused on bioconvergence—the integration of biology with engineering, automation and digital technologies. The company develops tools and technologies intended to support research, drug development, diagnostics and other applications in the life sciences.

Its product portfolio includes 3D bioprinters, bioinks, laboratory automation systems, precision dispensing equipment, advanced microscopy and imaging technologies, and software for managing and analyzing laboratory workflows. BICO’s offerings are marketed through a portfolio of specialized brands, including CELLINK, SCIENION, DISPENDIX, Nanoscribe, MatTek and Visikol.

The company was founded in 2016 as CELLINK and subsequently expanded through the development and acquisition of businesses serving research laboratories, pharmaceutical companies, biotechnology firms and academic institutions. BICO serves customers internationally, with operations and commercial activities spanning multiple regions, including North America, Europe and Asia.

Key Stats

• Today's Range: C$2.54 to C$2.54
• 50-Day Range: C$1.53 to C$2.51
• 52-Week Range: C$1.52 to C$2.56
• Volume: 600 shs
• Average Volume: 6,833 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CLLKF
• CIK: N/A
• Web: bico.com
• Phone: (463) 112-8700
• Fax: N/A
• Employees: 695
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A